Monday, January 16, 2017

Turmeric a Medicine - Enigmatic Medicinal Actions

        Turmeric a Medicine - Enigmatic Medicinal Actions

            Papineni Labs     Curcumin Infection Treatment - Clinical Imaging

Turmeric is a Medicine - established through centuries by a unique class of researchers practicing Ayurveda, Siddha, and other old world medicine.  Curcumin is a compound in turmeric with the golden medicinal property.   Pongal and Sankaranthi are major Indian Harvest Festival where turmeric is copiously used by everyone.  One can see loads of young turmeric all over the wet market.    

Waking up on this Pongal Day, I was really disappointed to see the following commentary titled “Deceptive curcumin offers cautionary tale for chemists” in one of the premier research journal http://www.nature.com/news/deceptive-curcumin-offers-cautionary-tale-for-chemists-1.21269.  The author of the commentary states that the turmeric extracts dupes assays and leads drug hunters astray.  The commentary highlights the review (K. M. Nelson et al. J. Med. Chem. http://dx.doi.org/10.1021/acs.jmedchem.6b00975; 2017), published on 11 January.  Here, the authors published a most comprehensive critical review on curcumin.  Their conclusions - no evidence in curcumin’s therapeutic benefits, despite thousands of research papers and more than 120 clinical trials is a big Jolt!  Sad to notice this auspicious root is getting a bad rap due to improper research approaches applied by many laboratories in evaluating the curcumin drug action mechanisms.  In many cases, sloppy science is a factor as discussed by the contributors of the above works.

This turmeric compound spreads its wings with a predatory effect on a billion dollar market in cure of a range of diseases from erectile dysfunction, hirsutism, baldness, cancer and Alzheimer’s disease. In fact, big establishments can go curries in this golden concoction.    

Everyone agrees turmeric has all the potential to be a true multi-tasking drug.  It’s just that, meticulous biochemical and pharmacological approaches aided with the cutting-edge molecular imaging and high-throughput assays need to be followed.  Here is a compound, Gold, that took a millennium to establish its medicinal properties in the east – scientific community can’t just throw hands up in despair and walk away within a decade. 

In Papineni Labs, my first attempt with curcumin on human skin disorder was promising. We designed and developed a Clinical Molecular Imaging System for early detection of cardiovascular changes in diabetes and other diseases http://www.fasebj.org/content/25/1_Supplement/815.13.short.  Using this first of its kind clinical optical imaging instrument, we tested effects of curcumin on ringworm infection as a proof-of-principle.  Ringworm is a common fungal infection that appears as patches of red ring on the skin.  We used the near infrared fluorescence (NIRF) imaging to image the infection and subsequent treatment using topical curcumin application.  In this work, non-invasive autofluorescence imaging was performed utilizing the natural fluorescence resultant of the fungal infection. Curcumin showed a success where over- the-counter and prescription drug treatments failed with a subject.  Curcumin did show a promise, a larger sample size and additional methodologies are needed to nail the mode of action. We reported this fluorescence based methodology at the World Molecular Imaging Congress WMIC 2011 San Diego, USA and in Bhubaneshwar (Society of Nuclear Medicine- India 2012).

Yes, our ancestors were right in terms of the medicinal properties of turmeric.  It is just quite complex to isolate the primary compounds from this elixir and to dissect its mode of action.  Not impossible, especially with developments in Imaging, animal models, mass spectrophotometers, and high throughput drug screening methods in hand.  


Madras (Chennai) News Item:
'


 




Dr. Rao V. L. Papineni

Professor (Adjunct- assistant)

University of Kansas Medical Center KUMC

USA


Dr. Rao V. L. Papineni is an Adjunct faculty member at University of Kansas Medical Center, and a molecular theragnostics scientist at PXI,  USA. He received his doctoral degree in Biochemistry from University of Hong Kong (British Terr). Dr. Papineni had his early education from University of Madras, where he earned his Bachelors and Master’s Degree. After ten years in Research and Faculty positions at University of Hong Kong and Baylor college of Medicine (USA), he joined Kodak/Carestream Health, USA.  Dr. Papineni has made several inventions and chaired scientific sessions in International Biomedical Meetings and serves on the editorial board of Nanotech and Experimental Pharmacology journals.  As a distinguished scientist, he initiated advanced research programs to study Inflammation and oncology utilizing molecular imaging and nanotechnology based molecular tools.  He recently identified and coined “Radiobioluminescence” a novel X-ray induced radiation phenomena that have immense potential in development of cancer therapeutic strategies.  His lab is instrumental in development of MIGRT  Molecular Image Guided Radiation Therapy technology and utilizing radiobiophotonics and MIGRT in Drug Discovery related to Cancer and radiation medicine.


 

http://www.radres.org/blogpost/961725/250704/Cancer-Therapy--Radiobiophotonics-with-Rao-Papineni
 

"Molecular Imaging - Wisdom to See for Maladies to Flee"
                                                          Dr. Rao V. L. Papineni